Because of the role of the RhoA/Rho kinase (ROCK) pathway in regulating numerous pathologic processes including vasoconstriction, vascular remodeling, and fibrosis, ROCK inhibitors may be especially beneficial in treating Raynaud's phenomenon and scleroderma. © 2008 Elsevier Inc. All rights reserved.
CITATION STYLE
Flavahan, N. A. (2008, February). Regulation of Vascular Reactivity in Scleroderma: New Insights into Raynaud’s Phenomenon. Rheumatic Disease Clinics of North America. https://doi.org/10.1016/j.rdc.2007.12.005
Mendeley helps you to discover research relevant for your work.